![](https://partners4access.com/wp-content/uploads/2022/02/oralITAv1-Copy-300x211.jpg)
Blogs
Value-based services and Orphan Drugs: Italy says yes
By Andrea Bernardini, Senior Analyst Email: abernardini@partners4access.com AIFA has approved reimbursement of the orphan drug Evrysdi (risdiplam) by Roche, the first at-home oral treatment for Spinal